The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Kura Oncology Inc. (KURA) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $11.22. The Kura Oncology Inc. has recorded 43,906 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Kura Oncology to Participate in Upcoming Investor Conferences.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $11.22 and fluctuated between $11.35 as its day high and $10.34 as its day low. The current market capitalization of Kura Oncology Inc. is $791.57M. A total of 0.54 million shares were traded on the day, compared to an average of 816.88K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, KURA has seen 3 BUY and 6 SELL insider trades, representing the acquisition of 56,875 and the disposition of 14,500 shares. Over the last 12 months, there were 5 BUYs and 12 SELLs from insiders. Insiders purchased 1,182,493 shares during that period but sold 1,640,208.
In the most recent transaction, DALE STEPHEN sold 9,225 shares of KURA for 13.88 per share on Jan 27. After the transaction, the Chief Medical Officer now owns 27,675 company shares. In a previous transaction on Jan 27, FLOWERS KIRSTEN sold 1,906 shares at 13.89 per share. KURA shares that CCO & Chief Strategy Officer owns now total 20,605.
Among the insiders who sold shares, FORD KATHLEEN disposed of 1,821 shares on Jan 27 at a per-share price of $13.89. This resulted in the Chief Operating Officer holding 21,214 shares of KURA after the transaction. In another insider transaction, DOYLE THOMAS JAMES sold 1,548 shares at $13.89 per share on Jan 27. Company shares held by the SVP, Finance & Accounting now total 16,841.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for KURA in the last 3 months, the mean price target is $31.80 with high estimates of $47.00 and low estimates of $22.00. In terms of 52-week highs and lows, KURA has a high of $19.93 and a low of $10.30.
As of this writing, KURA has an earnings estimate of -$0.57 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.53 per share and a lower estimate of -$0.65.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 11 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KURA is Hold with a score of 5.00. A total of 10 analysts rated the stock as Buy while 1 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.